Entry date | September 24, 2002 12:00 +1GMT
| Last update | April 28, 2019 20:51 +1GMT
|
Allergome Code | 71
|
Name | Asp f 2 
|
Previous Names | Asp f II
|
Common Names | Fibrinogen-binding Protein, m219
|
Biological Function | Fibrinogen Binding Protein?, Fibrinogen-binding Proteins
|
Isoforms, Variants, Epitopes | Asp f 2.0101
|
Links to Molecule Sequences | Asp f 2 - B0Y6E9 - UNIPROT, Asp f 2 - D3W9Z7 - UNIPROT, Asp f 2.0101 - P79017 - UNIPROT
|
Sources | |
Links to Source Taxonomy | Asp f - 746128 - NCBI, Asp f - 746128 - UniProt, Asp f - Discover Life, Asp f - Wikipedia
|
Links to Source Images | Aspergillus fumigatus on Google images | Tissues | Whole Body
|
Routes of Exposure | Inhalation
|
Epidemiology from Literature | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.270 | 20120528, Patelis A
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 1.010 | 20110223, De Knop KJ
| 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 0.000 | 20120528, Patelis A
| 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 0.000 | 20090826, Ebo DG
| 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 0.000 | 20091121, Ebo DG
| 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 0.000 | 20091121, Ebo DG
| 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 15.000 | 20091005, Ott H
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2007 | Germany | IgE | 8 | 100.000 | 20070305, RingerS
| 5.1.1 - Source Exposed (Symptoms) | 2002 | United States | IgE | 18 | 44.400 | 2002, McCann WA
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2000 | Switzerland | IgE | 24 | 87.000 | 2000a, Kurup VP
| 3.1.4 - Source Sensitized (SPT, IgE) | 2000 | Switzerland | IgE | 16 | 6.000 | 2000a, Kurup VP
| 5.4.2 - Source Exposed (Symptoms, SPT, high IgE) | 1997 | United States | IgE | 25 | 100.000 | 1997, Banerjee B
| 3.1.1 - Source Sensitized (SPT) | 1997 | United States | IgE | 10 | 10.000 | 1997, Banerjee B
|
| References | Biochemistry / Structure / Function 2014: 20140331, Lollier V
2011: 20110714, Gautam P
2010: 20101104, Fraczek MG
- 20100910, Singh B
- 20100303, Amich J
2008: 20081230, Cressman RF
- 20081028, Ivanciuc O
- 20080714, Oezguen N
- 20080411, Fedorova ND
- 20080128, Kanduc D
2007: 20070907, Soeria-Atmadja D
- 20070703, Gautam P
- 20070227, Bowyer P
2006: 20061017, Bowyer P
- 20060923, Westwood GS
- 20060704, Svirshchevskaya E
2005: 20051222, Nierman WC
2004: 20040201, Ivanciuc O
2002: 2002, Banerjee B
2000: 2000, Tang B
... complete Reference listing ->
Molecular Biology 2010: 20100303, Amich J
2002: 2002, Banerjee B
2000: 2000, Tang B
1999: 1999, Banerjee B
1998: 1998, Banerjee B
1996: 1996, Banerjee B
Immunochemistry / Allergenicity 2013: 20130820, Kespohl S
2010: 20100910, Singh B
2008: 20081028, Ivanciuc O
2007: 20070703, Gautam P
2002: 2002, Banerjee B
2000: 2000, Tang B
1999: 1999, Banerjee B
1998: 1998, Banerjee B
1997: 1997, Banerjee B
1996: 1996, Banerjee B
1993: 1993, Teshima R
Immune-mechanisms / Genetics 2003: 20031213, Knutsen AP
2001: 2001, Rathore VB
Detection - Source Extracts, Food Products, Drug Preparations 2010: 20101104, Fraczek MG
1999: 1999, Segurado M
1998: 1998, Banerjee B
Detection - Allergy Diagnostic and Immunotherapeutic Products 2013: 20130820, Kespohl S
Detection - Source Tissues 2010: 20100303, Amich J
Epidemiology 2012: 20120528, Patelis A
2011: 20111214, Zheng YW
2009: 20090826, Ebo DG
Diagnosis 2014: 20140609, Rentzos G
- 20140331, Rockmann H
- 20140324, Heaps A
2013: 20130820, Kespohl S
- 20130507, Agarwal R
- 20130129, Shokry D
2012: 20121004, Bonini M
- 20120725, Pascal M
- 20120720, Alessandri C
- 20120426, Sastre I
2011: 20110521, Melioli G
- 20110223, De Knop KJ
- 20110124, Postigo I
2009: 20091121, Ebo DG
- 20091005, Ott H
- 20090826, Ebo DG
- 20090210, Ohshima M
2007: 20070420, Giavina-Bianchi P
- 20070305, RingerS
2006: 20061019, Bowyer P
... complete Reference listing ->
Experimental Model - Allergic Immune Response 2006: 20060704, Svirshchevskaya E
2005: 20051023, Rivera A
Experimental Model - Inhalant-induced Diseases 2005: 20051103, Barrios CS
2004: 20040929, Svirshchevskaya EV
2002: 2002b, Kurup VP
- 2002, Bozza S
2001: 2001, Svirshchevskaya EV
Review, Editorial, Report Citations, Other Resources 2014: 20141118, Heinekamp T
- 20140513, Singh B
- 20140416, Denning DW
- 20140304, Shah A
2013: 20131108, Agarwal R
- 20131004, Canonica GW
- 20130810, Kleine-Tebbe J
2012: 20120712, Bumbacea RS
- 20120501, Mahdavinia M
- 20120405, Durr C
- 20120402, Bhetariya PJ
- 20120305, Matsumura Y
- 20120130, Knutsen AP
- 20120111, Treudler R
2011: 20111228, Prester L
- 20111003, Knutsen AP
- 20110523, Knutsen AP
2010: 20101214, Alessandri C
- 20101111, Delhaes L
- 20101026, Abad A
... complete Reference listing -> |
|